Levi Strauss & Co. SEC Filings

Capital Research Global Investors filed a Schedule 13G reporting its position in Levi Strauss & Co. common stock as a beneficial owner of 0 shares, representing 0.0% of the 104,585,522 shares the filing states are outstanding. The filing identifies CRGI as an investment adviser division of Capital Research and Management Company and related investment management entities and states that, collectively under the name Capital Research Global Investors, they are deemed to beneficially own 0 shares.

The filing shows 0 sole and 0 shared voting powers and 0 sole and 0 shared dispositive powers, and includes a certification that the securities (if any) are held in the ordinary course of business and not to influence control of the issuer.

Prime Joshua E, identified as a director of Levi Strauss & Co. (LEVI), acquired 137 dividend equivalent rights (DERs) on 08/08/2025 at a reported price of $0.00. Those DERs are contingent rights to receive one share of the companys Class A Common Stock upon settlement and vest in line with the underlying awards.

The filing shows 64,570 Class A shares beneficially owned by the reporting person following the transaction, held directly. Unvested DERs vest 100% on the earlier of the day before the next annual meeting or one year after grant; some underlying awards are already vested but subject to deferred delivery, with the same DER terms.

Patrick Artemis, a director of Levi Strauss & Co., reported the acquisition of 97 dividend equivalent rights (DERs) tied to Class A Common Stock on 08/08/2025, increasing his direct beneficial ownership to 14,076 shares. The DERs are contingent rights to receive one share each upon settlement and vest consistent with the underlying awards; unvested awards and related DERs accelerate to 100% vesting on the earlier of the day before the next annual meeting or the first anniversary of grant. Some underlying awards are fully vested but subject to a deferred delivery feature, which also applies to the related DERs.

Ming Jenny J, a director of Levi Strauss & Co. (LEVI), reported insider acquisitions on 08/08/2025 consisting of dividend equivalent rights (DERs) tied to the company's common stock. The filing shows the reporting person acquired 82 DERs that represent contingent rights to receive Class A common stock and 110 DERs that represent contingent rights to receive Class B common stock; the Class B DERs are noted as fully vested and subject to a deferral delivery feature. The report lists 64,442 shares of Class A common stock beneficially owned following the non-derivative transaction and 59,775 derivative securities beneficially owned following the reported derivative transaction. Each share of Class B common stock is convertible into one share of Class A common stock per the filing.

Christopher J. McCormick, a director of Levi Strauss & Co. (LEVI), reported awards and related contingent dividend-equivalent rights on 08/08/2025. The filing shows the acquisition of 213 dividend equivalent rights (DERs) tied to Class A Common Stock and 41 DERs tied to Class B Common Stock, both reported as acquired at a $0.00 price. After these transactions, the report lists 70,103 shares of Class A Common Stock and 57,464 shares (or equivalents) of Class A Common Stock underlying Class B holdings as beneficially owned directly. The DERs vest and settle consistent with underlying awards; unvested awards vest on the earlier of the day before the next annual meeting or one year after grant, and some DERs are fully vested but subject to deferred delivery.

Form 4 summary for LEVI: David S. Marberger, a director of Levi Strauss & Co., acquired 102 dividend equivalent rights (DERs) on 08/08/2025. Each DER represents a contingent right to receive one share of the issuer's Class A Common Stock upon settlement. The reported transaction increases the reporting person’s direct beneficial ownership to 22,645 shares following the reported transaction.

The DERs vest and are delivered consistent with the underlying awards: unvested awards and related DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the grant date. Certain underlying awards are fully vested but subject to deferred delivery; the same delivery terms apply to the related DERs.

Insider acquisition reported: Director Daniel W. Geballe acquired 80 dividend equivalent rights (DERs) tied to Levi Strauss & Co. Class A common stock on 08/08/2025. Each DER is a contingent right to receive one share upon settlement; the DERs vest 100% on the earlier of the day before the next annual stockholder meeting or the first anniversary of the related grant. The reported acquisition carried a $0.00 price and increased Mr. Geballe's direct beneficial ownership to 11,634 Class A shares. Some underlying awards may include a deferred delivery feature that applies equally to the DERs.

Garten Yael, a director of Levi Strauss & Co. (LEVI), reported the acquisition of 107 dividend equivalent rights (DERs) on 08/08/2025. Each DER is a contingent right to receive one share of the issuer's Class A Common Stock upon settlement; the transaction shows a price of $0.00 and the reporting table indicates 60,362 shares beneficially owned following the reported transaction, held directly.

The filing explains that the DERs vest and are delivered consistent with the underlying awards to which they relate. Unvested awards and related DERs vest 100% on the earlier of the day before the next Annual Stockholder Meeting or the first anniversary of the grant date; certain underlying awards are fully vested but subject to deferred delivery, and those same terms apply to the related DERs.

Spencer C. Fleischer, a director of Levi Strauss & Co. (LEVI), reported acquisitions of dividend equivalent rights that will convert into common stock upon settlement. On 08/08/2025 he acquired 213 DERs tied to Class A Common Stock and 187 DERs tied to Class B Common Stock, each recorded with a transaction code A and a price of $0.00. Following these acquisitions the report shows 64,500 shares of Class A Common Stock beneficially owned and 116,515 shares underlying derivative securities beneficially owned. The filing explains that DERs represent contingent rights to receive one share per DER upon settlement, vesting consistent with underlying awards and subject in some cases to deferred delivery, and notes Class B shares convert one-for-one into Class A shares.